Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic specialty Therapies (Neurovascular, ENT & Pelvic Health) — Worldwide Revenue ($M) ($M)
Medtronic Form 8-K Quarterly World-Wide Revenue Tables & Form 10-K/10-Q Segment Disclosures
Latest, Q1 FY27
774
Period ended Jul 31, 2026
Change on a year earlier
+10.3%
702 in Q1 FY26
History
45 quarters
Since Q1 FY16
Sources
41
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up specialty therapies (neurovascular, ent & pelvic health) — worldwide revenue ($m)
- Specialty Therapies (Neurovascular, ENT & Pelvic Health) — Organic Revenue Growth YoY (%)7.4% · Q1 FY27
- Specialty Therapies (Neurovascular, ENT & Pelvic Health) — Foreign Currency Impact ($M)6 · Q1 FY27
- Specialty Therapies (Neurovascular, ENT & Pelvic Health) — Reported Revenue Growth YoY (%)10.2% · Q1 FY27
- Specialty Therapies (Neurovascular, ENT & Pelvic Health) — U.S. Revenue ($M)447 · Q1 FY27
- Specialty Therapies (Neurovascular, ENT & Pelvic Health) — International Revenue ($M)326 · Q1 FY27
Cite this data
StockData. (2026). Medtronic Specialty Therapies (Neurovascular, ENT & Pelvic Health) — Worldwide Revenue ($M) ($M), quarterly Q1 FY16–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/neuro-st-ww-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.